Related Experiment Video

Updated: Dec 17, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.0K

Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer

Sho Ueno1, Min Woo Kim2, Gibok Lee3

  • 1Graduate School of Science and Technology (GSST), Kumamoto University, Kumamoto 860-8555, Japan.

Pharmaceutics
|July 1, 2020
PubMed

Insights

Researchers developed ErbB2-targeting liposomes (ErbB2Lipo) using peptides for enhanced chemotherapy delivery in ErbB2-positive breast cancer, offering a cost-effective alternative to antibody therapies.

Area of Science:

  • Oncology
  • Nanotechnology
  • Pharmacology

Background:

  • ErbB2 receptor tyrosine kinase is implicated in cancer progression and treatment resistance.
  • Therapeutic antibodies targeting ErbB2 are effective but costly and require repeated administration.
  • Peptides offer a cheaper, more stable, and less immunogenic alternative for targeted drug delivery.

Purpose of the Study:

  • To develop a novel peptide-targeted drug delivery system for ErbB2-positive breast cancer.
  • To enhance the therapeutic efficacy of rapamycin and overcome drug resistance.
  • To create a cost-effective and efficient alternative to antibody-based therapies.

Main Methods:

  • Construction and physicochemical characterization of ErbB2-targeting liposomes (ErbB2Lipo).
  • Comparison of ErbB2-targeting peptides with scrambled peptides (ScrErbB2).
  • Evaluation of liposome delivery efficiency in ErbB2-positive BT-474 cells.

Main Results:

  • Successful synthesis of ErbB2Lipo confirmed by physicochemical characterization.
  • ErbB2-targeting peptides demonstrated specific binding compared to scrambled peptides.
  • ErbB2Lipo showed significantly higher delivery efficiency in ErbB2-positive cells than non-targeting liposomes.

Conclusions:

  • Peptide-targeted liposomes represent a promising strategy for improving chemotherapy in ErbB2-positive cancers.
  • This approach offers a potentially more effective and economical treatment option.
  • The developed system could overcome limitations associated with current antibody therapies.
Keywords:
breast cancer therapydrug delivery systemimmunoliposomemTOR inhibitortargeted therapytargeting peptide

More Related Videos

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

11.3K
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.3K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
124
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K